Analysts' Actions: FDX, BWLD, GILD, MGM

NEW YORK (TheStreet) -- CHANGE IN RATINGS

ABB Ltd. downgraded at to Neutral from Buy, UBS said. $21.79 price target. Stock has not reacted to warnings from peers, risk to downside.

Aon downgraded at KBW from Outperform to Market Perform, Keefe, Bruyette & Woods said. Company is leveraged to Europe.

Associated Banc-Corp upgraded to buy at TheStreet Ratings.

Buffalo Wild Wings downgraded at Miller Tabak from Buy to Hold, Miller Tabak said. $72 price target. Wing costs remain high.

Cracker Barrel downgraded at Keybanc from Buy to Hold, Keybanc said. Valuation call, based on a $55 price target.

Colfax upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $42 price target. Charter acquisition should add to earnings.

FedEx upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $112 price target. Company is gaining market share in the U.S.

Corning upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $16 price target. Earnings growth should resume in 2013.

Hittite Microwave downgraded at Needham from Buy to Hold, Needham said. Valuation call, based on a $58 price target.

Alliant Energy upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Valuation call. Estimates also boosted, given higher expected regulated utility earnings.

MDC Holdings upgraded at Goldman to Buy, Goldman Sachs said. Stock trades at a 30% discount to its peers and sports a solid 4.1% dividend yield. $30 price target.

MGM Resorts downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $14.50 price target.

MWI Veterinary downgraded at Barrington from Outperform to Market Perform, Barrington Research said. Growth rate may not be sustainable.

PNC Financial downgraded at BMO from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $65 price target.

Polypore upgraded at Baird from Neutral to Outperform, Robert Baird said. $58 price target. Stock is largely pricing in near-term risks.

State Street downgraded at Evercore from Overweight to Equal-weight, Evercore Partners said. Valuation call, based on a $43 price target.

Teva Pharmaceutical downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, based on a $47 price target.

Weyerhaeuser downgraded at UBS to Sell from Neutral, UBS said. $18 price target. Valuation call.

STOCK COMMENTS / EPS CHANGES

Alliant Techsystems numbers lowered at Jefferies. Shares of ATK now seen reaching $72, Jefferies said. Estimates also lowered on a challenging outlook from a drawdown in Afghanistan. Buy rating.

American Axle & Manufacturing target raised at Jefferies. Shares of AXL now seen reaching $10, Jefferies said. Shares have had far and away the biggest move in the group since the October 3 lows. Underperform rating.

Walt Disney numbers boosted at Goldman. Shares of DIS now seen reaching $43. Estimates also upped, as the company is buying back more stock. Neutral rating.

Diamond Offshore numbers cut at UBS. Shares of DO now seen reaching $70, according to UBS. Estimates also lowered on higher opex and tax rate. Buy rating.

Gilead Sciences numbers increased at ThinkEquity through 2013, ThinkEquity said. Company continues to see success in its pipeline. Buy rating and new $61 price target.

Iconix Brand Group target raised at Citigroup to $24, Citigroup said. Still undervalued given FCF and growth opportunity. Buy rating.

Marathon Petroleum target raised at Oppenheimer to $55, Oppenheimer said. Share buybacks and MLP likely to boost valuation. Outperform rating.

National Fuel Gas numbers reduced at BMO. Shares of NFG now seen reaching $60. Estimates also cut, given weaker gas prices. Market Perform rating.

National Oilwell Varco numbers raised at BMO. Shares of NOV now seen reaching $101, according to BMO Capital. Estimates also increased, as the company is seeing higher growth across the board. Outperform rating.

Panera Bread target raised at Oppenheimer. Shares of PNRA now seen reaching $175, Oppenheimer said. Unique traffic drivers and strong operating leverage. Outperform rating.

Patterson-UTI numbers cut at BMO. PTEN estimates were reduced through 2013, BMO Capital said. Company is seeing lower pressure pumping results. Market Perform rating.

Regeneron Pharmaceuticals numbers raised at Jefferies. Shares of REGN now seen reaching $111, Jefferies said. Estimates also raised on DME sales opportunity. Buy rating.

Sirona Dental numbers raised at Morgan Stanley. Shares of SIRO now seen reaching $54, according to Morgan Stanley. Guidance will likely prove conservative. Overweight rating.

Tenneco added to Conviction Buy List at Goldman. Company can gain market share. $50 price target.

Thomson Reuters numbers cut at Credit Suisse. Shares of TRI now seen reaching $32, according to Credit Suisse. Estimates also reduced, given challenges in the financial industry. Neutral rating.

Volcano estimates, target upped at Goldman. VOLC estimates were boosted through 2015, Goldman Sachs said. Company is gaining market share. Neutral rating and new $28 price target.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.